Press "Enter" to skip to content

Novo Nordisk Options Trading: A Deep Dive into Market Sentiment


Financial giants have made a conspicuous bullish move on Novo Nordisk. Our analysis of options history for Novo Nordisk NVO revealed 10 unusual trades.

Delving into the details, we found 60% of traders were bullish, while 40% showed bearish tendencies. Out of all the trades we spotted, 3 were puts, with a value of $102,960, and 7 were calls, valued at $574,779.

Expected Price Movements

After evaluating the trading volumes and Open Interest, it’s evident that the major market movers are focusing on a price band between $60.0 and $115.0 for Novo Nordisk, spanning the last three months.

Analyzing Volume & Open Interest

In terms of liquidity and interest, the mean open interest for Novo Nordisk options trades today is 971.4 with a total volume of 1,071.00.

In the following chart, we are able to follow the development of volume and open interest of call and put options for Novo Nordisk’s big money trades within a strike price range of $60.0 to $115.0 over the last 30 days.

Novo Nordisk Option Activity Analysis: Last 30 Days


Biggest Options Spotted:

Symbol PUT/CALL Trade Type Sentiment Exp. Date Strike Price Total Trade Price Open Interest Volume
NVO CALL SWEEP BEARISH 01/16/26 $115.00 $363.3K 107 208
NVO CALL TRADE BULLISH 01/16/26 $60.00 $51.8K 56 10
NVO CALL SWEEP BULLISH 03/15/24 $100.00 $41.7K 1.7K 57
NVO CALL SWEEP BEARISH 03/15/24 $105.00 $39.6K 4.7K 137
NVO PUT SWEEP BULLISH 01/16/26 $110.00 $39.1K 15 32

About Novo Nordisk

With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (constituting roughly 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.

Having examined the options trading patterns of Novo Nordisk, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance

Novo Nordisk’s Current Market Status

  • With a trading volume of 2,900,082, the price of NVO is up by 0.79%, reaching $106.51.
  • Current RSI values indicate that the stock is may be approaching overbought.
  • Next earnings report is scheduled for 5 days from now.

What Analysts Are Saying About Novo Nordisk

Over the past month, 1 industry analysts have shared their insights on this stock, proposing an average target price of $120.0.

  • An analyst from Morgan Stanley has revised its rating downward to Overweight, adjusting the price target to $120.

Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.

If you want to stay updated on the latest options trades for Novo Nordisk, Benzinga Pro gives you real-time options trades alerts.


This post was originally published on this site

Be First to Comment

Leave a Reply

Your email address will not be published. Required fields are marked *